Global Compound Bone Peptide for Injection Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Compound Bone Peptide for Injection Consumption 2016-2026

2.1.2 Compound Bone Peptide for Injection Consumption CAGR by Region

2.2 Compound Bone Peptide for Injection Segment by Type

2.2.1 Intramuscular Injection

2.2.2 Intravenous Drip

2.3 Compound Bone Peptide for Injection Sales by Type

2.3.1 Global Compound Bone Peptide for Injection Sales Market Share by Type (2016-2021)

2.3.2 Global Compound Bone Peptide for Injection Revenue and Market Share by Type (2016-2021)

2.3.3 Global Compound Bone Peptide for Injection Sale Price by Type (2016-2021)

2.4 Compound Bone Peptide for Injection Segment by Application

2.4.1 Rheumatism

2.4.2 Rheumatoid Arthritis

2.4.3 Osteoporosis

2.4.4 Cervical spondylosis

2.4.5 Post-fracture healing

2.4.6 Others

2.5 Compound Bone Peptide for Injection Sales by Application

2.5.1 Global Compound Bone Peptide for Injection Sale Market Share by Application (2016-2021)

2.5.2 Global Compound Bone Peptide for Injection Revenue and Market Share by Application (2016-2021)

2.5.3 Global Compound Bone Peptide for Injection Sale Price by Application (2016-2021)

3 Global Compound Bone Peptide for Injection by Company

3.1 Global Compound Bone Peptide for Injection Sales Market Share by Company

3.1.1 Global Compound Bone Peptide for Injection Sales by Company (2019-2021)

3.1.2 Global Compound Bone Peptide for Injection Sales Market Share by Company (2019-2021)

3.2 Global Compound Bone Peptide for Injection Revenue Market Share by Company

3.2.1 Global Compound Bone Peptide for Injection Revenue by Company (2019-2021)

3.2.2 Global Compound Bone Peptide for Injection Revenue Market Share by Company (2019-2021)

3.3 Global Compound Bone Peptide for Injection Sale Price by Company

3.4 Global Manufacturers Compound Bone Peptide for Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Compound Bone Peptide for Injection Product Location Distribution

3.4.2 Players Compound Bone Peptide for Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Compound Bone Peptide for Injection by Region

4.1 Global Compound Bone Peptide for Injection by Region

4.1.1 Global Compound Bone Peptide for Injection Sales by Region

4.1.2 Global Compound Bone Peptide for Injection Revenue by Region

4.2 Americas Compound Bone Peptide for Injection Sales Growth

4.3 APAC Compound Bone Peptide for Injection Sales Growth

4.4 Europe Compound Bone Peptide for Injection Sales Growth

4.5 Middle East & Africa Compound Bone Peptide for Injection Sales Growth

5 Americas

5.1 Americas Compound Bone Peptide for Injection Sales by Country

5.1.1 Americas Compound Bone Peptide for Injection Sales by Country (2016-2021)

5.1.2 Americas Compound Bone Peptide for Injection Revenue by Country (2016-2021)

5.2 Americas Compound Bone Peptide for Injection Sales by Type

5.3 Americas Compound Bone Peptide for Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Compound Bone Peptide for Injection Sales by Region

6.1.1 APAC Compound Bone Peptide for Injection Sales by Region (2016-2021)

6.1.2 APAC Compound Bone Peptide for Injection Revenue by Region (2016-2021)

6.2 APAC Compound Bone Peptide for Injection Sales by Type

6.3 APAC Compound Bone Peptide for Injection Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Compound Bone Peptide for Injection by Country

7.1.1 Europe Compound Bone Peptide for Injection Sales by Country (2016-2021)

7.1.2 Europe Compound Bone Peptide for Injection Revenue by Country (2016-2021)

7.2 Europe Compound Bone Peptide for Injection Sales by Type

7.3 Europe Compound Bone Peptide for Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Compound Bone Peptide for Injection by Country

8.1.1 Middle East & Africa Compound Bone Peptide for Injection Sales by Country (2016-2021)

8.1.2 Middle East & Africa Compound Bone Peptide for Injection Revenue by Country (2016-2021)

8.2 Middle East & Africa Compound Bone Peptide for Injection Sales by Type

8.3 Middle East & Africa Compound Bone Peptide for Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Compound Bone Peptide for Injection Distributors

10.3 Compound Bone Peptide for Injection Customer

11 Global Compound Bone Peptide for Injection Market Forecast

11.1 Global Compound Bone Peptide for Injection Forecast by Region

11.1.1 Global Compound Bone Peptide for Injection Forecast by Regions (2021-2026)

11.2.2 Global Compound Bone Peptide for Injection Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Compound Bone Peptide for Injection Forecast by Type

11.7 Global Compound Bone Peptide for Injection Forecast by Application

12 Key Players Analysis

12.1 Jiangshi Pharma

12.1.1 Jiangshi Pharma Company Information

12.1.2 Jiangshi Pharma Compound Bone Peptide for Injection Product Offered

12.1.3 Jiangshi Pharma Compound Bone Peptide for Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Jiangshi Pharma Main Business Overview

12.1.5 Jiangshi Pharma Latest Developments

12.2 Zhitong Biopharma

12.2.1 Zhitong Biopharma Company Information

12.2.2 Zhitong Biopharma Compound Bone Peptide for Injection Product Offered

12.2.3 Zhitong Biopharma Compound Bone Peptide for Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Zhitong Biopharma Main Business Overview

12.2.5 Zhitong Biopharma Latest Developments

12.3 Xinbai Pharmaceutical

12.3.1 Xinbai Pharmaceutical Company Information

12.3.2 Xinbai Pharmaceutical Compound Bone Peptide for Injection Product Offered

12.3.3 Xinbai Pharmaceutical Compound Bone Peptide for Injection Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Xinbai Pharmaceutical Main Business Overview

12.3.5 Xinbai Pharmaceutical Latest Developments

...

13 Research Findings and Conclusion

Table 1. Compound Bone Peptide for Injection Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Intramuscular Injection

Table 3. Major Players of Intravenous Drip

Table 4. Global Compound Bone Peptide for Injection Sales by Type (2016-2021) & (K Units)

Table 5. Global Compound Bone Peptide for Injection Sales Market Share by Type (2016-2021)

Table 6. Global Compound Bone Peptide for Injection Revenue by Type (2016-2021) & ($ million)

Table 7. Global Compound Bone Peptide for Injection Revenue Market Share by Type (2016-2021)

Table 8. Global Compound Bone Peptide for Injection Sale Price by Type (2016-2021)

Table 9. Global Compound Bone Peptide for Injection Sales by Application (2016-2021) & (K Units)

Table 10. Global Compound Bone Peptide for Injection Sales Market Share by Application (2016-2021)

Table 11. Global Compound Bone Peptide for Injection Value by Application (2016-2021)

Table 12. Global Compound Bone Peptide for Injection Revenue Market Share by Application (2016-2021)

Table 13. Global Compound Bone Peptide for Injection Sale Price by Application (2016-2021)

Table 14. Global Compound Bone Peptide for Injection Sales by Company (2019-2021) & (K Units)

Table 15. Global Compound Bone Peptide for Injection Sales Market Share by Company (2019-2021)

Table 16. Global Compound Bone Peptide for Injection Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Compound Bone Peptide for Injection Revenue Market Share by Company (2019-2021)

Table 18. Global Compound Bone Peptide for Injection Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Compound Bone Peptide for Injection Producing Area Distribution and Sales Area

Table 20. Players Compound Bone Peptide for Injection Products Offered

Table 21. Compound Bone Peptide for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Compound Bone Peptide for Injection Sales by Region (2016-2021) (K Units)

Table 25. Global Compound Bone Peptide for Injection Sales Market Share by Region (2016-2021)

Table 26. Global Compound Bone Peptide for Injection Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Compound Bone Peptide for Injection Revenue Market Share by Region (2016-2021)

Table 28. Americas Compound Bone Peptide for Injection Sales by Country (2016-2021) & (K Units)

Table 29. Americas Compound Bone Peptide for Injection Sales Market Share by Country (2016-2021)

Table 30. Americas Compound Bone Peptide for Injection Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Compound Bone Peptide for Injection Revenue Market Share by Country (2016-2021)

Table 32. Americas Compound Bone Peptide for Injection Sales by Type (2016-2021) & (K Units)

Table 33. Americas Compound Bone Peptide for Injection Sales Market Share by Type (2016-2021)

Table 34. Americas Compound Bone Peptide for Injection Sales by Application (2016-2021) & (K Units)

Table 35. Americas Compound Bone Peptide for Injection Sales Market Share by Application (2016-2021)

Table 36. APAC Compound Bone Peptide for Injection Sales by Region (2016-2021) & (K Units)

Table 37. APAC Compound Bone Peptide for Injection Sales Market Share by Region (2016-2021)

Table 38. APAC Compound Bone Peptide for Injection Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Compound Bone Peptide for Injection Revenue Market Share by Region (2016-2021)

Table 40. APAC Compound Bone Peptide for Injection Sales by Type (2016-2021) & (K Units)

Table 41. APAC Compound Bone Peptide for Injection Sales Market Share by Type (2016-2021)

Table 42. APAC Compound Bone Peptide for Injection Sales by Application (2016-2021) & (K Units)

Table 43. APAC Compound Bone Peptide for Injection Sales Market Share by Application (2016-2021)

Table 44. Europe Compound Bone Peptide for Injection Sales by Country (2016-2021) & (K Units)

Table 45. Europe Compound Bone Peptide for Injection Sales Market Share by Country (2016-2021)

Table 46. Europe Compound Bone Peptide for Injection Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Compound Bone Peptide for Injection Revenue Market Share by Country (2016-2021)

Table 48. Europe Compound Bone Peptide for Injection Sales by Type (2016-2021) & (K Units)

Table 49. Europe Compound Bone Peptide for Injection Sales Market Share by Type (2016-2021)

Table 50. Europe Compound Bone Peptide for Injection Sales by Application (2016-2021) & (K Units)

Table 51. Europe Compound Bone Peptide for Injection Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Compound Bone Peptide for Injection Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Compound Bone Peptide for Injection Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Compound Bone Peptide for Injection Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Compound Bone Peptide for Injection Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Compound Bone Peptide for Injection Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Compound Bone Peptide for Injection Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Compound Bone Peptide for Injection Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Compound Bone Peptide for Injection Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Compound Bone Peptide for Injection

Table 61. Key Application and Potential Industries of Compound Bone Peptide for Injection

Table 62. Key Challenges of Compound Bone Peptide for Injection

Table 63. Key Trends of Compound Bone Peptide for Injection

Table 64. Compound Bone Peptide for Injection Distributors List

Table 65. Compound Bone Peptide for Injection Customer List

Table 66. Global Compound Bone Peptide for Injection Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Compound Bone Peptide for Injection Consumption Market Forecast by Region

Table 68. Global Compound Bone Peptide for Injection Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Compound Bone Peptide for Injection Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Compound Bone Peptide for Injection Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Compound Bone Peptide for Injection Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Compound Bone Peptide for Injection Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Compound Bone Peptide for Injection Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Compound Bone Peptide for Injection Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Compound Bone Peptide for Injection Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Compound Bone Peptide for Injection Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Compound Bone Peptide for Injection Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Compound Bone Peptide for Injection Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Compound Bone Peptide for Injection Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Compound Bone Peptide for Injection Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Compound Bone Peptide for Injection Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Compound Bone Peptide for Injection Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Compound Bone Peptide for Injection Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Compound Bone Peptide for Injection Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Compound Bone Peptide for Injection Revenue Market Share Forecast by Application (2021-2026)

Table 86. Jiangshi Pharma Basic Information, Compound Bone Peptide for Injection Manufacturing Base, Sales Area and Its Competitors

Table 87. Jiangshi Pharma Compound Bone Peptide for Injection Product Offered

Table 88. Jiangshi Pharma Compound Bone Peptide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Jiangshi Pharma Main Business

Table 90. Jiangshi Pharma Latest Developments

Table 91. Zhitong Biopharma Basic Information, Compound Bone Peptide for Injection Manufacturing Base, Sales Area and Its Competitors

Table 92. Zhitong Biopharma Compound Bone Peptide for Injection Product Offered

Table 93. Zhitong Biopharma Compound Bone Peptide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Zhitong Biopharma Main Business

Table 95. Zhitong Biopharma Latest Developments

Table 96. Xinbai Pharmaceutical Basic Information, Compound Bone Peptide for Injection Manufacturing Base, Sales Area and Its Competitors

Table 97. Xinbai Pharmaceutical Compound Bone Peptide for Injection Product Offered

Table 98. Xinbai Pharmaceutical Compound Bone Peptide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Xinbai Pharmaceutical Main Business

Table 100. Xinbai Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Compound Bone Peptide for Injection

Figure 2. Compound Bone Peptide for Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Compound Bone Peptide for Injection Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Compound Bone Peptide for Injection Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Compound Bone Peptide for Injection Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Intramuscular Injection

Figure 10. Product Picture of Intravenous Drip

Figure 11. Global Compound Bone Peptide for Injection Sales Market Share by Type in 2020

Figure 12. Global Compound Bone Peptide for Injection Revenue Market Share by Type (2016-2021)

Figure 13. Compound Bone Peptide for Injection Consumed in Rheumatism

Figure 14. Global Compound Bone Peptide for Injection Market: Rheumatism (2016-2021) & (K Units)

Figure 15. Compound Bone Peptide for Injection Consumed in Rheumatoid Arthritis

Figure 16. Global Compound Bone Peptide for Injection Market: Rheumatoid Arthritis (2016-2021) & (K Units)

Figure 17. Compound Bone Peptide for Injection Consumed in Osteoporosis

Figure 18. Global Compound Bone Peptide for Injection Market: Osteoporosis (2016-2021) & (K Units)

Figure 19. Compound Bone Peptide for Injection Consumed in Cervical spondylosis

Figure 20. Global Compound Bone Peptide for Injection Market: Cervical spondylosis (2016-2021) & (K Units)

Figure 21. Compound Bone Peptide for Injection Consumed in Post-fracture healing

Figure 22. Global Compound Bone Peptide for Injection Market: Post-fracture healing (2016-2021) & (K Units)

Figure 23. Compound Bone Peptide for Injection Consumed in Others

Figure 24. Global Compound Bone Peptide for Injection Market: Others (2016-2021) & (K Units)

Figure 25. Global Compound Bone Peptide for Injection Sales Market Share by Application (2016-2021)

Figure 26. Global Compound Bone Peptide for Injection Revenue Market Share by Application in 2020

Figure 27. Compound Bone Peptide for Injection Revenue Market by Company in 2020 ($ Million)

Figure 28. Global Compound Bone Peptide for Injection Revenue Market Share by Company in 2020

Figure 29. Global Compound Bone Peptide for Injection Sales Market Share by Regions (2016-2021)

Figure 30. Global Compound Bone Peptide for Injection Revenue Market Share by Region in 2020

Figure 31. Americas Compound Bone Peptide for Injection Sales 2016-2021 (K Units)

Figure 32. Americas Compound Bone Peptide for Injection Revenue 2016-2021 ($ Millions)

Figure 33. APAC Compound Bone Peptide for Injection Sales 2016-2021 (K Units)

Figure 34. APAC Compound Bone Peptide for Injection Revenue 2016-2021 ($ Millions)

Figure 35. Europe Compound Bone Peptide for Injection Sales 2016-2021 (K Units)

Figure 36. Europe Compound Bone Peptide for Injection Revenue 2016-2021 ($ Millions)

Figure 37. Middle East & Africa Compound Bone Peptide for Injection Sales 2016-2021 (K Units)

Figure 38. Middle East & Africa Compound Bone Peptide for Injection Revenue 2016-2021 ($ Millions)

Figure 39. Americas Compound Bone Peptide for Injection Sales Market Share by Country in 2020

Figure 40. Americas Compound Bone Peptide for Injection Revenue Market Share by Country in 2020

Figure 41. Americas Compound Bone Peptide for Injection Sales Market Share by Type in 2020

Figure 42. Americas Compound Bone Peptide for Injection Sales Market Share by Application in 2020

Figure 43. United States Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 44. Canada Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 45. Mexico Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 46. Brazil Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 47. APAC Compound Bone Peptide for Injection Sales Market Share by Region in 2020

Figure 48. APAC Compound Bone Peptide for Injection Revenue Market Share by Regions in 2020

Figure 49. APAC Compound Bone Peptide for Injection Sales Market Share by Type in 2020

Figure 50. APAC Compound Bone Peptide for Injection Sales Market Share by Application in 2020

Figure 51. China Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 52. Japan Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 53. Korea Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 54. Southeast Asia Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 55. India Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 56. Australia Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 57. Europe Compound Bone Peptide for Injection Sales Market Share by Country in 2020

Figure 58. Europe Compound Bone Peptide for Injection Revenue Market Share by Country in 2020

Figure 59. Europe Compound Bone Peptide for Injection Sales Market Share by Type in 2020

Figure 60. Europe Compound Bone Peptide for Injection Sales Market Share by Application in 2020

Figure 61. Germany Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 62. France Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 63. UK Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 64. Italy Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 65. Russia Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 66. Middle East & Africa Compound Bone Peptide for Injection Sales Market Share by Country in 2020

Figure 67. Middle East & Africa Compound Bone Peptide for Injection Revenue Market Share by Country in 2020

Figure 68. Middle East & Africa Compound Bone Peptide for Injection Sales Market Share by Type in 2020

Figure 69. Middle East & Africa Compound Bone Peptide for Injection Sales Market Share by Application in 2020

Figure 70. Egypt Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 71. South Africa Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 72. Israel Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 73. Turkey Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 74. GCC Country Compound Bone Peptide for Injection Revenue Growth 2016-2021 ($ Millions)

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles